Vaccines with interleukin-33 as an adjuvant
US10130705B2 · kind B2 · utility
0Cited by
1References
22Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 2, 2014 |
| Grant date | Nov 20, 2018 |
| Priority date | — |
| Expiry date | Dec 31, 2034 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein is a vaccine comprising an antigen and IL-33. Also disclosed herein is a method for increasing an immune response in a subject in need thereof. Further disclosed herein is a method for treating cancer in a subject in need thereof. The methods may comprise administering the vaccine to the subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.